Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") candidate, SER-252, for advanced ...
Study Finds on MSN
New blood test shows promise for faster ALS diagnosis
No more waiting months, or even over a year, for an ALS diagnosis? In A Nutshell A 46-gene blood test identified ALS patients ...
WAYNE, Mich. (WXYZ) — If you or a loved one is facing long-term care choices, figuring out what to do can be overwhelming.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果